Hoag Family Cancer Center
1 Hoag Drive, Newport Beach, CA 92658
949-557-0117
Histotripsy is a precise, non-invasive cancer treatment option and the only FDA-approved therapy of its kind for treating liver tumors. As one of only a few sites in the country to offer this revolutionary technology, Hoag is proud to provide patients access to the latest FDA-approved treatment options and therapies.





Histotripsy is a non-invasive, incisionless treatment that uses targeted ultrasound waves to wipe out cancer cells. The sound waves produce mini bubbles within the tumor, creating pressure to eradicate unhealthy cells, all while keeping surrounding liver structures and healthy tissue intact.
This FDA-approved treatment is performed by Hoag interventional radiologists and can coincide with chemotherapy and other treatment methods. Histotripsy has little to no side effects and patients usually go home the same day.

Hoag is one of only two hospitals in the state of California and few in the nation to provide histotripsy – a futuristic treatment technology for combatting liver cancer and liver tumors.
The combined expertise of Hoag Digestive Health Institute and Hoag Family Cancer Institute gives you access to the most advanced diagnostics, therapies and treatment options as well as groundbreaking clinical research.
Hoag offers the leading comprehensive Liver Program in Orange County, ensuring seamless, coordinated care from diagnosis through treatment – so you can trust that you will have exceptional care.
Our subspecialized team uses advanced diagnostics and therapies including interventional radiology. Hoag’s advanced imaging techniques, precise endoscopic diagnosis and staging, as well as noninvasive endoscopic treatment methods mean you receive the very best care.
Hoag Digestive Health Institute and Hoag Family Cancer Institute clinicians work together to provide liver cancer patients with the very latest treatment options, resulting in better outcomes.
Between our multidisciplinary group of fellowship-trained subspecialists in hepatology, liver surgery, endoscopy and diagnostic and interventional radiology and our care counselor and dietician, we help guide you through your entire care journey. Additionally, we conduct a Liver Case Conference where we discuss complex cases of liver cancer in a multidisciplinary fashion to foster collaboration to drive improved outcomes.

<p>Dr. Alexander Misono specializes in Vascular & Interventional Radiology.</p> <p>Dr. Misono joined NHRA in 2018. He is a graduate of Harvard College (AB), Harvard Business School (MBA), and Harvard Medical School (MD). He completed internship in internal medicine at Beth Israel Deaconess Medical Center, a Harvard Medical School teaching hospital. He then trained in the Diagnostic Radiology residency program at Massachusetts General Hospital and Harvard Medical School. Following that, he completed training as a fellow in Vascular & Interventional Radiology at the Miami Cardiac & Vascular Institute, a world-renowned center for the diagnosis, management, and treatment of vascular disease.</p> <p>Dr. Misono has served on numerous committees and been an invited speaker at annual meetings of the Society of Interventional Radiology (SIR) and American College of Radiology (ACR). Dr. Misono is an active researcher in the fields of radiology and interventional radiology, having presented or published over 50 scientific presentations, abstracts, book chapters, and peer-reviewed publications in journals such as the Journal of the American Medical Association (JAMA), Journal of the American College of Radiology (JACR), Journal of Vascular & Interventional Radiology (JVIR), and American Journal of Roentgenology (AJR).</p>

<p>Dr. Trushar Patel joined NHRA in 2014. He specializes in Vascular and Interventional Radiology with a focus in Interventional Oncology and Venous Disease. After finishing residency at Cornell Medical Center with additional training at Memorial Sloan Kettering Cancer Center, Dr. Patel completed a fellowship in Vascular and Interventional Radiology at the University of California, San Francisco.</p>

<p>Dr. Tust Techasith specializes in Vascular and Interventional Radiology, with particular emphasis on minimally invasive treatment of cancer and venous disease.</p> <p>Dr. Techasith graduated from Harvard Medical School in 2011. He completed his internship at Santa Clara Valley Medical Center where he was awarded Intern of the Year. He subsequently completed both his residency training in Diagnostic Radiology, serving as chief resident, and fellowship training in Vascular and Interventional Radiology at Stanford University Medical Center.</p> <p>Dr. Techasith has authored or co-authored over 30 scientific abstracts, book chapters, and peer-reviewed publications in the field of diagnostic and interventional radiology. He has also been an invited lecturer at various residency training programs, universities, and national meetings.</p>